PharmacoCheck+
Commercial- Indications
- Drug metabolism
Company intelligence / Profile preview
PreCheck Health Services operates a CLIA-certified and CAP-accredited laboratory offering advanced molecular diagnostics with a focus on precision medicine. Their FDA-approved SolidTumorCheck+ NGS assay profiles over 500 cancer-relevant genes to guide targeted therapy selection. The company provides comprehensive hereditary cancer risk panels as well as custom panels in immunology, neurology/endocrinology/cardiopulmonary genetics. They also offer pharmacogenomic testing to optimize medication choices based on individual genetic makeup. Clinical results are delivered in physician-ready reports with actionable recommendations.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PreCheck Health Services.